Boscoe has been investing in equities across the health care spectrum since 2000. Before joining First Light, he managed a therapeutic portfolio consisting of pharmaceutical, biotechnology, specialty pharmaceutical and generic companies for Citadel Global Equities. Prior to that position, Boscoe was a founding partner and senior health care analyst for Blue Jay Capital Management where he invested across the entire health care universe with a focus on therapeutics and health care services. He also was a founding partner and senior health care analyst for Expo Capital Management, a health care sector hedge fund, where he covered the biotechnology, pharmaceutical, medical technology, diagnostics and health care services industries. Additionally, Boscoe was a senior health care analyst for Vantis Capital Management and Seneca Capital Management; a biotechnology equity research analyst and equity research senior associate for Morgan Stanley; and a managed care equity research associate for Credit Suisse First Boston/Donaldson, Lufkin & Jenrette.